TrialClinical drug investigation2008

Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.

Peter H Jones et al.PubMed ↗Publisher ↗

No numbers read from the abstract.